Aura Biosciences opened lower at $7.53, compared with its previous close of $7.61. In the last trading session, the stock traded between $7.08 and $7.53. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Aura Biosciences is now worth
$ 41.25
Resulting in a loss of
$ 58.75 (58.75%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 1 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.49 (-6.49%)
Day High
$7.53
Day Low
$7.08
Day Open
$7.53
Prev Close
$7.61
Volume
8,49,637
1W Return
6.94%
1M Return
8.94%
3M Return
-11.44%
6M Return
-13.11%
1Y Return
25.72%
Fundamentals
Market Cap ($ Mn)
741
PE Ratio
-
PB Ratio
2.27
PEG Ratio
-
ROE
-70.97%
ROCE
-68.51%
EPS (TTM)
$-0.31
Investment Returns
1 Week
6.94%
1 Month
8.94%
3 Months
-11.44%
6 Months
-13.11%
9 Months
26.62%
Financials
Quarterly
All values in $ Mn
0.0
Jun 25
0.0
Sep 25
0.0
Dec 25
0.0
Mar 26
0.0
Jun 26
0.0
Sep 26
Updates
9Nov
Aura Biosciences Q3 loss narrows to $(0.29), beats estimate
Aura Biosciences posted a Q3 loss of $(0.29) per share. The result beat the analyst consensus of $(0.37) by 21.62%. Losses narrowed 27.5% YoY from $(0.40) in the same period last year.
3 days ago
19Oct
Aura Q3FY26 Results: Earnings call scheduled for November 12, 2026
Aura releases Q3FY26 financial results on November 12, 2026. Appendix 4C and Quarterly Activities Report due October 30, 2026. Earnings webcast scheduled for 10:30 am AEDT on November 12, 2026.
25 days ago
3Sep
Aura Biosciences CEO to speak at Morgan Stanley healthcare conference
Natalie Holles, CEO and President, will speak at the Morgan Stanley 24th Annual Global Healthcare Conference. The fireside chat is scheduled for September 16, 2026, at 2:35 pm ET. A live webcast will be available on the company's investor relations website. The Phase 3 study for bel-sar in early choroidal melanoma is fully enrolled.
2mo ago
2Sep
Aura Biosciences grants equity inducement awards to three new executives
Aura Biosciences granted inducement equity awards to three new executives under Nasdaq Rule 5635(c)(4). Erica Kratz, Susan Abu-Absi, and Julie Person received stock options and restricted stock units. All option awards have an exercise price of $7.43 per share, set at the September 1 closing price. Awards vest over four years, with significant portions tied to long-term service continuity.
2mo ago
12Aug
Aura Biosciences may offer securities up to $500M aggregate
Aura Biosciences filed to offer up to $500M in securities, including $200M in common stock via Jefferies. This filing enables flexible capital raising through a structured sales agreement.
